Canadian’s New Food Guide Moving Away From Meat Consumption – Give it a try with us during Meat Free Week!

Canadian’s New Food Guide Moving Away From Meat Consumption – Give it a try with us during Meat Free Week!

In the past two decades, Canadians have shifted towards a diet which includes more fruits and vegetables, cereal products, and nuts and beans.

With more and more Canadians making the switch, it is no wonder that Health Canada just released its preliminary draft of Canada’s new Food Guide, the first such overhaul of the country’s nutrition policy in ten years. The changes are long overdue, say health care experts, many of whom see the proposal as a step in the right direction.

The preliminary draft highlights include:

• The importance of adding whole foods to your diet, specifically plant-based foods (such as legumes) as a preferred source of protein
• Regular intake of vegetables, fruit, whole grains and protein-rich foods, especially plant-based sources of protein
• A shift away from animal foods by advising that people eat foods with unsaturated fat instead of saturated fat

Even though statistics in the last 3 decades show a steady decline in Canadian meat consumption, there are still many meat lovers that remain skeptical about making the switch despite the World Health Organization’s classification of red meat – including, beef, veal, pork, lamb, mutton, horse, and goat – as “probably carcinogenic to humans”.
WHO found an even stronger link between processed meat – such as salami and hotdogs, and bowel cancer.

Studies conducted by the World Cancer Research Fund show bowel cancer risk increases by 17% per 100g of red meat consumed per day and that bowel cancer risk increases by 18% per 50g of processed meat consumed per day.

• ¼ cooked hamburger = 80g
• 8 oz steak = 170g
• Spaghetti Bolognese sauce = 100g
• 1 large sausage = 40g processed meat
• 3 slices of ham = 70g processed meat

Read more about how you can reduce your bowel cancer risk.

Try Going Meatless For a Week With Us!

People around the world will be going meatless next week including all of us at Colorectal Cancer Canada for Meat Free Week (18th-24th September 2017). This new campaign challenges participants to give up meat for seven days and raise funds for a great cause.

Going meat free for one week creates a great opportunity to start thinking about how much meat you eat and the impact eating too much meat can have.

Everyone is invited to take the Meat Free Week challenge and discover how easy it is to make little changes that can create a big difference. Challenge yourself, your family, your friends and colleagues to give up meat for seven days.

Sign up for Meat Free Week and raise funds for a great cause!

Not able to participate, but still want to help make real change happen? Make a donation today.

If you’re already living meat free, there are still plenty of ways you can get involved in Meat Free Week.

+ Meat Free Week: Live well. Eat well. Be well.

• Adopt a physically active lifestyle.
• Consume a healthy diet with an emphasis on plant-based foods.
• Maintain a healthy body weight.

Are you following our healthy our foods that fight cancer program?
Once you’ve made it through Meat Free Week, this is a great on-going support program that can help you eat better and live healthier.

Check us out today via our website or facebook page!

About Foods That Fight Cancer

Who Are We?

We are believers of FOOD.

We want to empower Canadians to take charge & take over their health!

So Welcome fellow food enthusiast! Learn about foods here, find your favorites recipes, invite your friends & family, and TAKE OVER your kitchen & your health!

References:

http://www.statcan.gc.ca/pub/21-020-x/2009001/part-partie1-eng.htm
https://www.cantechletter.com/2017/07/look-meat-eaters-canadas-new-food-guide-will-turn-vegetarian/

Using Epigenetics as Biomarkers for Colorectal Cancer

Using Epigenetics as Biomarkers for Colorectal Cancer

By Marc Aurèle Chay

http://www.genengnews.com/gen-news-highlights/pan-cancer-epigenetic-signature-readable-in-circulating-tumor-dna/81252334

http://www.genengnews.com/gen-news-highlights/pan-cancer-epigenetic-signature-readable-in-circulating-tumor-dna/81252334

In Canada, screening for colorectal cancer can be done using the FOBT or FIT tests. These currently have suboptimal diagnostic accuracy, which is why researchers are investigating other avenues for non-invasive detection of early CRC. Scientists have found that in many early-stage cancers, including CRC, epigenetic alterations are present in much higher frequency than genetic mutations. As such, DNA methylation, ncRNAs, histone modifications are being investigated for potential diagnostic and prognostic markers of CRC.

DNA Methylation Biomarkers

Blood, stool, saliva and urine are being examined by the research community for these markers. DNA methylation in particular is being studied extensively, and some groups have reported sensitivities of 90-95% with specificity ranges of 85-94% for certain biomarkers in CRC. Some genes have risen to be the most promising markers, including the tumor specific M2 isoform of pyruvate kinase (PKM2), tissue inhibitor of matrix metalloproteinase 1 (TIMP1), vimentin (VIM) and septin 9 (SEPT9). DNA methylation is also being investigated for prognostic biomarkers and predictive markers for response to treatment. In particular, CpG island methylator phenotype (CIMP) positive cancers are found to correlate strongly with overall unfavorable prognosis, but seem to benefit from 5-FU based adjuvant chemotherapy. Hypermethylated Transcription Factor AP-2 Epsilon (TFAP2E) seems to also predict response to 5-FU based chemotherapy.

Histone Modification Biomarkers

Diagnostic and prognostic biomarkers using histone modifications have been much less studied, partly due to technical limitations of assays that are used to characterize the chromatin landscape. Some studies show acetylation of H3 lysine 56 and di- or tri-methylation of H3 lysine 9 and 27 have potential to be prognostic markers in CRC. These results are still currently preliminary and are expected to be further explored with the new bioinformatic tools and next-generation sequencing technologies that are being optimized.

Non-Coding RNA Biomarkers

On the other hand, non-coding RNAs, and in particular miRNAs, have triggered a substantial interest from the scientific community. Blood and stool based biomarkers have been investigated, and multiple candidates such as miR-21, miR-92a, miR17-3p or miR-106a have come up as potential diagnostic markers. MiR-21 has also been associated with poor patient survival, and several other miRNAs have been proposed as prognostic markers. As research evolves, scientists hope to engineer a panel of biomarkers that will be able to accurately identify and predict prognosis for early stage CRCs.

Epigenetics has offered us new tools to understand the complex etiology of colorectal cancer. As the scientific community further elucidates the mechanisms at play, epigenetic biomarkers to diagnose, classify and predict prognosis of CRC are also uncovered. Further research on these biomarkers may provide us with high performance assays that can be used to prevent and better manage patients with CRC.

References

Mitchell, S.M., Ho, T., Brown, G.S., Baker, R.T., Thomas, M.L., McEvoy, A., Xu, Z.-Z., Ross, J.P., Lockett, T.J., Young, G.P., LaPointe, L.C., Pedersen, S.K., Molloy, P.L., 2016. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer. Genes (Basel) 7. doi:10.3390/genes7120125

Okugawa, Y., Grady, W.M., Goel, A., 2015. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology 149, 1204–1225.e12. doi:10.1053/j.gastro.2015.07.011

Rozalski, R., Gackowski, D., Siomek-Gorecka, A., Banaszkiewicz, Z., Olinski, R., 2016. Urinary Measurement of Epigenetic DNA Modifications: A Non-Invasive Assessment of the Whole-Body Epigenetic Status in Healthy Subjects and Colorectal Cancer Patients. ChemistryOpen 5, 550–553. doi:10.1002/open.201600103

Sameer, A.S., Nissar, S., 2016. Epigenetics in diagnosis of colorectal cancer. Mol Biol Res Commun 5, 49–57.

Sazanov, A.A., Kiselyova, E.V., Zakharenko, A.A., Romanov, M.N., Zaraysky, M.I., 2016. Plasma and saliva miR-21 expression in colorectal cancer patients. J. Appl. Genet. doi:10.1007/s13353-016-0379-9

Understanding What Epigenetic Means in Colorectal Cancer

Understanding What Epigenetic Means in Colorectal Cancer

By Marc Aurèle Chay

Vaiopoulos, A.G., Athanasoula, K.C., Papavassiliou, A.G., 2014. Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842, 971–980. doi:10.1016/j.bbadis.2014.02.006

Vaiopoulos, A.G., Athanasoula, K.C., Papavassiliou, A.G., 2014. Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease 1842, 971–980. doi:10.1016/j.bbadis.2014.02.006

Consider the genome as words in a book, and epigenetics as the punctuation and accents that dictate the way each sentence is read. Epigenetic regulation refers to the heritable and reversible mechanisms that alter gene expression without affecting the underlying DNA sequence. Epigenetic mechanisms, among others, include DNA methylation, non-coding RNAs, chromatin remodelers and histone post-translational modifications. They play a crucial role in the proper functioning of a cell. In cancer, genetic and epigenetic alterations are linked together and can both contribute to the activation of oncogenes and/or the silencing of tumor suppressors. In colorectal cancer (CRC), understanding the epigenetic mechanisms driving pathogenesis have been a focus of the scientific community since the early 2000s. Many potential driver aberrations have been found, but as with genetic mutations, there isn’t a single mechanism that can explain CRC development.

DNA Methylation in CRC

DNA methylation refers to the addition of a methyl group to a nucleotide, usually a cytosine in a CG context. When present at CpG islands, it correlates strongly with repression of the nearest gene. Researchers have found global genomic hypomethylation, especially in CIN CRCs, as well as hypermethylation in promoter regions of specific genes such as APC, Cadherin-1 (CDH1), runt-related transcription factor 3 (RUNX3), mutL homolog 1 (MLH1), O-6-methylguanine-DNA methyltransferase (MGMT), cyclin-dependent kinase inhibitor 2A (CDKN2A), and RASSF1A.

Histone Modifications in CRC

Other than DNA methylation are histone post-translational modifications. These are the addition of methyl/acetyl/ubiquityl/phosphate groups to the proteins that make up nucleosomes. The modifications regulate the way DNA is compacted in the nucleus, and recruit various proteins involved in activation or repression of gene expression. In CRC, many genes encoding of proteins responsible for these histone modifications are dysregulated, thus changing the epigenomic landscape of the cell. For example, histone deacetylase 2(HDAC2) is upregulated in the early steps of CRC. HDAC1-3, 5 and 7 have also been reported to be upregulated in CRC. Dysregulation of Lysine specific demethylase 1 (LSD1), which interacts with tumor suppressor p53, seems also to increase the proliferation, invasion and metastatic potential of CRC cells.

Non-Coding RNAs in CRC

Another type of epigenetic mechanism which can modulate gene expression in CRC is the non-coding RNAs which include the micro-RNAs (miRNA), and long-non-coding RNAs (lncRNA). For example, the miR-200 family are known to be implicated in cancer invasion and migration; the hox transcript antisense intergenic RNA (HOTAIR) is correlated to advanced CRC and enhanced metastatic potential of cancer cells.

Epigenetics is still a relatively new field of research. As scientists strive to elucidate the etiology of colorectal cancer, they discover new potential mechanisms at play. Understanding the epigenetic basis of CRC may open the door for new drugs and biomarkers, so be on the lookout!







References:

Bardhan, K., Liu, K., 2013. Epigenetics and Colorectal Cancer Pathogenesis. Cancers (Basel) 5, 676–713. doi:10.3390/cancers5020676

Sameer, A.S., Nissar, S., 2016. Epigenetics in diagnosis of colorectal cancer. Mol Biol Res Commun 5, 49–57.

Sazanov, A.A., Kiselyova, E.V., Zakharenko, A.A., Romanov, M.N., Zaraysky, M.I., 2016. Plasma and saliva miR-21 expression in colorectal cancer patients. J. Appl. Genet. doi:10.1007/s13353-016-0379-9

Vaiopoulos, A.G., Athanasoula, K.C., Papavassiliou, A.G., 2014. Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease 1842, 971–980. doi:10.1016/j.bbadis.2014.02.006

The CCAC shares its stories of survival to encourage hope for a better future

The CCAC shares its stories of survival to encourage hope for a better future

barryBarry Stein – CCAC Founder & CEO
Diagnosed with stage IV metastatic colon cancer in 1995

‘Upon my diagnosis I knew very little, if anything, about cancer except that I had to fight. I wanted to do everything possible to improve my situation, but I had no experience and I understood very little of the information given to me. I vowed to do as much research as I could so that I would be able to make informed decisions about my treatment.

My determination proved to be a very important first step in my cancer journey and as a survivor. I now know that colorectal cancer is preventable, treatable and beatable. That’s why I have devoted my life since 1995 to making others aware of the disease, supporting patients and their families and working hard across Canada both for the implementation of screening programs, as well as equal and timely access to effective treatments to improve patient outcomes.’

Over 20 years ago Barry Stein’s vision to create a better, more preventive and equally accessible medical environment for all Canadians touched by colorectal cancer was put into motion with the birth of the Colorectal Cancer Association of Canada (CCAC). His mission was threefold: Awareness, Advocacy and Education, the three pillars needed to implement change for a cancer free future.

As part of their programs, the CCAC developed numerous monthly support groups across the country to create a meeting place for patients, their families and caregivers to talk about their individual situations and exchange ideas of how to help each other through not only their struggles but their successes as well. The CCAC’s dedicated cancer coaches furnish attendees with valuable information by sharing up to date information about the most current therapies designed to help them. Participants have said they come away from the meetings empowered with vital knowledge each time. Here are a few stories of people the CCAC has helped over the years:

Elan Freedy
Diagnosed with Stage IIIB Rectal Cancer

Elan felt in perfect health before his annual checkup and a rectal exam to check his prostate found microscopic traces of blood. Both his GP and GI told him it was probably nothing based on his young age but recommended a colonoscopy just in case.
“The day of the diagnosis still seems likes a dream in my memory. I remember feeling like it can’t be real.

I was lucky to have such a supportive and loving family and wife who took amazing care of me through all stages of my treatment. I also feel lucky to have made some amazing friends who are my peers in this journey and have greatly enriched my life. I think everyone who goes through the journey comes out stronger and with a better perspective on life than when they went into it.”

UntitledFrank Formusa
Diagnosed with Stage IV Colon Cancer

Frank Formusa began his journey with cancer at 66.

In the fall of 2012, his Oncologist suggested that he may be a candidate for a Hepatic Arterial Infusion Pump – a procedure unavailable in Canada during that time. He wrote to various Provincial and Federal agencies to advocate for the procedure to be done in Canada. In doing so, he met Barry Stein who shared his own successful personal journey with colon cancer and introduced him to Filomena Servidio-Italiano – leader of one of the CCAC support groups.

“This is not a disease that one should go through by themselves. To go to the CCAC meetings is to have a safe place for patients and their families to be really listened to and appreciated. We have left every meeting feeling more informed and with a more positive outlook.

Thank you CCAC – Thank you Filomena! I am so grateful to have met you and to know that you are there for us and for so many just like us.”

jamie 1Jamie Mead
Diagnosed Stage IV Colon Cancer two weeks shy of her 28th birthday

Her diagnosis stemmed from acid reflex complaints at a walk in clinic.

“I have had my surgeon admit that he never thought he would see me again after our first meeting. But with determination, a positive attitude and the will to keep on living – I have proved everyone wrong. I know this is not the end of my battle against colon cancer. I will be fighting this for the rest of my life, but that is ok. I am not thankful for cancer – that would be crazy – I am thankful for other things it has given me. I have a greater appreciation for all those who surround my life. It has made me into a person I didn’t know existed.”

IMG_0289Linda Wilkins
Diagnosed with Stage IV Colorectal Cancer in August 2005

 
After her surgery to remove the primary tumour along with about 75 percent of her colon, followed by a full round of chemotherapy, Linda was introduced to the CCAC and its support groups.

“It is now seven years later and I am still ‘No Evidence of Disease’.  Perhaps I am the exception, but I learned that the most important lesson here is to be your own advocate and I pass it along to anyone who will listen, thanks to the CCAC and the invaluable support they offered through CCRAN (CCAC support groups). I OWE THEM MY LIFE.

UntitledMarie Taurasi
Diagnosed Stage III rectal Cancer in January 2015

When Marie was diagnosed she had very few symptoms. But following a colonoscopy her world and that of her husband and two children (ages 13 and 17) came crashing down.
“Throughout this journey, with the education, support and guidance of the CCAC, I have learned a lot about this disease. Most importantly, I learned this is not just an old person’s disease! This disease affects men and women of all ages. It does not discriminate.

The CCAC is here for people like you and me. People who desperately require support, guidance and above all education, so that we can get through the ups and downs that we go through when battling this horrible disease.

I am so fortunate that I started my journey with the CCAC because without their help I would not be “cancer-free today”! What a gift they gave to me and to my precious children and husband! Thank you CCAC, for all the support and guidance you have given us. You truly are “Angels!”

197Werner Muehlemann
Diagnosed with Stage IV Colorectal Cancer at 28

When Werner went to see his doctor about some problems he was having he was told that he had nothing to worry about because he was young and in good shape. Following a few tests he was diagnosed with colorectal cancer.

“In that moment, I saw my life flash before my eyes – my career and dreams of getting married and starting a family vanishing.

The CCAC helped me acquire all the information that I needed to understand my treatments to follow in the months ahead and ultimately beat colorectal cancer. The CCAC also helped my family get the information they needed to support me in my long journey.

My dream for the future is that colorectal cancer screening becomes as routine as going to the dentist.”

Never Too Young for Colorectal Cancer

Never Too Young for Colorectal Cancer

NTY Coalition_final logo Colorectal cancer no longer discriminates on age. While colorectal cancer incidences and mortality rates in Canadians aged 50+ have been declining in recent years due to increased screening and surveillance programs, the opposite is unfortunately being reported for our younger population.

In the last few years, Canadian doctors have observed a rapid increase in the number of patients under age 50 with colorectal cancer. What makes it even more concerning is that they cannot explain why.

The study also found that younger patients are getting diagnoses at later stages making them harder to treat and leading to increasing fatalities. These shocking statistics reveal that there is more work to be done in terms of prevention and treatment of colorectal cancer in Canada – especially for young adults.


In the last year, the CCAC has partnered with the Never Too Young (“N2Y”) Coalition, an organization united to take action on young onset of colorectal cancer through action, education, and research. The Coalition includes medical professionals, patient advocacy organizations, cancer survivors and caregivers working to educate the public about this growing issue and to reduce the number of late stage young-onset colorectal cancer cases.

Together with the N2Y coalition, the CCAC provides support and information to young patients in Canada who have experienced early onset of the disease.

Young patients may not always understand the signs and symptoms of colorectal cancer, which may delay their seeking medical attention. Symptoms of CRC can vary from blood in the stool, abdominal discomfort, constipation and much more.

According to the Canadian Cancer Society, men are more at risk than women for the disease. Eating processed and red meats, a lack of dietary fiber, a lack of physical exercise, obesity, alcohol, smoking, diabetes and genetics are also identified as risk factors.

Younger patients should consider the following when speaking to their doctors about their inherited risk or symptoms for colorectal cancer:

Family Tree

About 10% of the population has a first degree relative with colon or rectal cancer. If it is evident in your family tree, it is recommended to start screening as early as the age of 25.

Lynch Syndrome

Changes in certain genes increase your risk of colon cancer.
Lynch Syndrome is the most common type of inherited colon cancer, accounting for about 2% of all colon cancer cases. Lynch syndrome is a mutation of a gene that is responsible for fixing errors in your DNA. Lynch Syndrome, also known as hereditary nonpolyposis colon cancer (HNPCC), is an hereditary disorder caused by a genetic mutation in which affected individuals have a higher than normal chance of developing colorectal cancer, endometrial cancer, and various other types of aggressive cancers, often at a young age. To prevent colorectal cancer, people with Lynch Syndrome should undergo a colonoscopy every 1-2 years, starting in their twenties. Doing this will reduce the risk of colorectal cancer by 77%.

References:
http://www.ctvnews.ca/health/rapid-increase-in-colorectal-cancers-among-young-canadians-study-finds-1.2919527

The Backbone of the CCAC is its Supporters

The Backbone of the CCAC is its Supporters

action-changes-things The CCAC is dedicated to colorectal cancer awareness and education, supporting patients and their families, and advocating on their behalf. Like most non-profit organizations, we rely on donations and money collected from fundraising events to maintain the services and programs we offer. As a result, throughout the year we host numerous campaigns and events to ensure we maintain our promise of working towards change for a better colorectal cancer free future.

As always, we invite our many supporters to participate either by attending or sponsoring our events and campaigns which include, Dress in Blue Day, Scotiabank Marathons, our annual Gala in Montreal, Foods That Fight Cancer, Never Too Young and Decembeard, to name a few.

However, in addition, we are very lucky and thankful to have numerous supporters across the country that host their own fundraising events in honor of a loved one affected by colorectal cancer. These individuals not only have our support via promotional or educational materials required but also have access to local staff or volunteers available to ensure their event’s success. Previous volunteer hosted events include; golf/baseball tournaments, luncheons, dinners, concerts, fashion shows, movie nights, art exhibitions and auctions.

Should you be interested in joining our volunteer staff or hosting a local event of your own, please do not hesitate to contact Frank Pitman at frankp@colorectal-cancer.ca.

Upcoming Fundraising CCAC events:

Dress in Blue
Dress in Blue Day happens annually on the first Friday of March to celebrate Colorectal Cancer Awareness Month; activities go on all month long. On this day, we engage schools, businesses, community groups and individuals to help us call attention to colorectal cancer awareness and spread lifesaving knowledge on prevention.

You can engage by hosting denim days and blue costume contests at offices and schools, holding local fundraising events, getting involved on social media and so much more. To be part of Dress in Blue Day and for any further information go to dressinblue.ca. We would love to see a colorectal cancer free world, please be part of the success by showing support!

Raise awareness for Colorectal Cancer

Raise awareness for Colorectal Cancer

Survivor The whole month of March is dedicated to Colorectal Cancer Awareness. The month where the Colorectal Cancer Association of Canada strives to raise awareness about the importance of screening and offers support to those touched by the disease.

Colorectal cancer is the second leading cause of cancer related deaths in Canada, yet it can be detected through simple screening tests. Colorectal cancer affects everyone, young and old, male or female. Although the prevalence of the disease increases at about 50 years old, many young individuals are touched by the disease, and the CCAC makes a point in offering them support.

The CCAC’s mission is Awareness, Education, Support and Advocacy. They continue to develop new events and programs across the country, with the goal of having a strong voice in every Canadian city.

This month, is also Nutrition month which ties in perfectly with the Foods That Fight Cancer program, a program that aims to celebrate a healthy lifestyle and primary prevention of cancer. We have also aligned with our alliance partners all over the world to promote the Never Too Young (N2Y) campaign supporting young patients diagnosed with the disease.

To beat this disease, we need the world to know how it can lower its risks through healthy lifestyles and screening.

We are in this fight together and will one day be able to proudly say that we beat this disease together!

March Colorectal Cancer Awareness Month

March Awareness_FB TW BANNER (1)This March, join Canadians across the country to honor all those affected by colorectal cancer during Colorectal Cancer Awareness Month. Last year alone, an estimated 26,100 Canadians were diagnosed with colorectal cancer. One in 12 men and one in 14 women are expected to develop colorectal cancer during their lifetime.

Despite the fact that colorectal cancer is Preventable, Treatable, and Beatable, it remains the second leading cancer killer in our nation. It does not discriminate against sex nor age. In past generations it was a disease more commonly found in individuals 50 years and over. However, statistics now show that more young people are being diagnosed, particularly those with Lynch syndrome.

Awareness, education and prevention through timely screening and healthy lifestyles are key to survival. Consequently, the Colorectal Cancer Association of Canada (CCAC) programs and campaigns are designed with this goal in mind, particularly to our younger population through our Never Too Young (N2Y) campaign.

butt picOn March 3rd, you can help support the CCAC and our patients by organizing a “Dress in Blue” Day at your work place. By dressing in Blue and raising funds for important CCAC programs, you will be spreading awareness of the disease, supporting patients and their families. It’s a simple and fun way to help us help you! For more information and to register your workplace, see: http://ccac.donordrive.com/event/515.

During awareness month, we are also celebrating the success of our Foods That Fight Cancer (FTFC) program under the direction of Dr. Richard Béliveau. FTFC’s goal is to help Canadians make the right food choices that will not only help prevent cancer, but also increase the chances of survival.
By supporting the CCAC, not only are you becoming part of the fight against cancer, you are helping to develop important programs and support for patients across the country who struggle to meet the challenges of this disease. “Patients now have more options to treat this disease than ever before. New treatments may completely change the manner in which we treat this disease. I am more optimistic than ever before that we can prolong lives longer and ultimately find a cure”, said Barry D. Stein, president of the CCAC.

We need your help to get the word out to save a life! Please donate to help us help you!
Together we can make a difference!

Visit our website or follow us on social media for a full list of our upcoming March Awareness Month events.

Twitter
Facebook
Instagram
Foods That Fight Cancer

For the Love of Awareness & Prevention

On February 14, 2017, The Giant Colon Tour visited the Jean-Coutu Pavilion at the Université de Montréal. This well attended event was held in the impressive Morris and Rosalind-Goodman atrium in partnership with students from the Department of Pharmacy. The goal of this activity was to raise awareness of colorectal cancer, discuss the benefits of screening and healthy lifestyles, and learn how to prevent the disease. With the theme “In the Heart of the Colon” in honor of St. Valentine’s Day, hundreds of students walked through the Giant Colon with great curiosity and enthusiasm. In addition, several staff members took a few minutes of their busy day to visit this impressive awareness exhibit. The students also organized a photo contest where the participants took a picture with The Giant Colon and published them on Facebook under #colongeantudem for a chance to win several prizes. The event was a real success and the CCAC is proud to have been a part of this event at this famous Montreal university.

Upcoming Giant Colon Tour Stops:

March 4th -5th: Giant Colon in the Yukon
March 16th-17th: Giant Colon Oshawa
March 24th-25th: Giant Colon Kahnawake

BUM RUN FUN-DRAISING FOR A GOOD CAUSE

unnamed (1) On Sunday April 30th at 7:30 AM, at Queen’s Park Circle in Toronto, Balanse Bum Run will host its 6th annual fundraising event to benefit colorectal cancer associations across Canada (including the CCAC) in support of their fight against Canada’s second leading cancer killer.
Bums of all ages and fitness levels are invited to partake as part of a team or fly solo by lacing up to walk/run to raise awareness and education of colorectal cancer. Little Bums can register for a shorter 1 km walk/run starting at 7:40am. The Little Bums race is a free event for children under 12 years of age.

If you live in the area, please join us! There will be food, prizes, music, press, CCAC’s ever-growing popular 40-foot long by 8-foot high, pink inflatable walk-through Giant Colon, and so much more!

“BUM RUN is an awesome event. My family and I have been participating for the past 2 years and we plan to participate again this year to raise funds for the wonderful CCAC and to spread the word that colorectal cancer is preventable through screening. I don’t want anyone to go through what I went through when I was diagnosed with stage III rectal cancer. So spread the word: BUM RUN is back! Sunday, April 30th.” Marie Taurasi who is a stage III rectal cancer survivor

As the CCAC will be one of 6 charities to benefit from the proceeds raised at the event we are calling on you to assist in one of two ways:

1. Participate in the event by walking/running: You can register for the event, set up your very own fundraising page furnished by “Running Room” and then have donations pour in! Simply click here to register:

OR…

2. Support the cause by donating to one of our team members fundraising page. Here is the link to her fundraising page:

All proceeds will go to the CCAC’s patient support and educational programs. Tax receipts will be instantly generated and online donations are secure.

BUM RUN HISTORY

The Bum Run is a not for profit organization founded by Dr. Ian Bookman, a gastroenterologist in Toronto, with the goal of raising awareness about colorectal cancer screening to prevent the 95% of cancer deaths which still needlessly occur.

Its mission is to increase awareness of the commonality of colorectal cancer today and to increase participation in screening programs to prevent colorectal cancer. In doing so, each year the event selects a list of charities to support in their fundraising initiatives. The charities have been selected based on their performance record in saving lives through promoting easy access to screening and proposal of use of the funds raised.